Weimar, 1 July 2019 - IBU-tec advanced materials AG ("IBU-tec", ISIN: DE000A0XYHT5) has launched a comprehensive, medium-term strategic alignment program for its subsidiary BNT Chemicals ("BNT"), which was acquired last year. This action is expected to result in significantly increased profitability for BNT Chemicals by 2022. In the course of the strategic review, measures were initiated at BNT which are expected to result in significantly higher contributions to IBU-tec Group earnings in the current fiscal year than had been previously forecast. This, in conjunction with extremely positive developments in the battery materials sector, gives the Executive Board of IBU-tec great confidence in projecting that EBITDA for the Group in 2019 will be at the upper end of the previous forecast of 7.2 - 7.5 million EUR range.
Ulrich Weitz, CEO of IBU-tec: "The successful integration of BNT with the rapid implementation of optimization plans lays the groundwork for further processes improvements and the realization of innovative solutions for IBU-tec. We fully expect BNT to achieve better-than-predicted earning results in the current fiscal year than had been initially forecast. Coupled with the surge in demand for e-mobility and stationary energy storage, we are extremely confident about the continuing positive development of the Group."
IBU-tec advanced materials AG is a highly specialized, high-growth, development and production service provider for the thermal process engineering industry for the treatment of inorganic powders and granules. These treatments give the substances modified and superior material properties. The core business services of IBU-tec have been greatly expanded by the addition of BNT’s product portfolio, firmly rooted in the tin and the wet chemistry sectors, and thus greatly improving Group market positioning as well as significantly increasing the potential for value creation.
IBU-tec addresses worldwide megatrends such as green mobility (e-mobility and automotive catalysts), green economy (including CO2-reduced building materials, rare earths, stationary energy storage) and medical technology (including artificial joints and dental prostheses) through its broad, international customer base. IBU-tec's market success is based on its own flexible technology platform, unique patented processes and the comprehensive know-how of its 235 employees.
Further information may be found at www.ibu-tec.de
edicto GmbH Axel Mühlhaus Eschersheimer Landstraße 42-44 60322 Frankfurt Tel. +49 (0) 69-905505-52 E-Mail: IBU-tec(at)edicto.de
IBU-tec advanced materials AG Max Narr Hainweg 9-11 99425 Weimar Phone +49 (0) 151 67955683 E-Mail: max.narr(at)ibu-tec.de